Skip to main content
. 2019 Jan 9;9:793. doi: 10.3389/fendo.2018.00793

Table 2.

Serum GDF15 levels before and after thionamide treatment in hyperthyroid subjects.

Before After P-value
N 43 43
Weight (kg) 52.23 ± 6.26 57.00 ± 7.33 <0.01
ALT (U/L) 37.81 ± 15.92 20.98 ± 9.32 <0.001
AST (U/L) 30.98 ± 12.28 20.63 ± 6.81 <0.001
TBIL (mmol/L) 14.66 ± 7.47 12.08 ± 4.32 0.053
DBIL (mmol/L) 4.88 ± 3.25 3.56 ± 1.61 0.019
FINS (mm/L) 10.69 ± 13.1 8.85 ± 6.81 0.416
FPG (mM) 5.14 ± 0.76 5.01 ± 0.44 0.335
TG (mM) 0.99 ± 0.68 1.11 ± 0.62 0.392
TC (mM) 3.66 ± 0.87 5.50 ± 1.01 <0.001
HDL-c (mM) 1.37 ± 0.39 1.66 ± 0.32 <0.001
Free T3 (pM) 26.62 ± 19.40 4.53 ± 0.83 <0.001
Free T4 (pM) 66.24 ± 32.78 13.05 ± 2.63 <0.001
TSH (mIU/L) 0.011 ± 0.016 0.86 ± 1.28 <0.001
GDF15 (pmol/L) 293.27 ± 119.49 118.10 ± 71.83 <0.001

Data are presented as means ± standard deviation (SD).